Shearwood McClelland, MD, a member of Case CCC's Population and Cancer Prevention Program, is the corresponding author for the study "Disparities in access to radiotherapy among Hispanic/Latinx ...
Over recent decades, advances in cancer treatment have yielded substantial improvements in patient outcomes, driving up survival, and even rendering some cancers curable. These advances have been ...
Menopausal Hormone Therapy and Ovarian and Endometrial Cancers: Long-Term Follow-Up of the Women's Health Initiative Randomized Trials Cancers with homologous recombination deficiency (HRD) can ...
SEATTLE – September 27, 2024 – Researchers at Fred Hutch Cancer Center identified a substantial increase over the past decade in the proportion of patients with cancer in the U.S. who participate in ...
- New case studies on first-line pancreatic cancer patients treated with atebimetinib in combination with FOLFIRINOX to be shared by trial investigators – - Conference call scheduled for Wednesday, ...
SUCCEED trial enables remote participation for small cell lung cancer patients, addressing location barriers and enhancing research opportunities. NXP800 shows promise in recurrent, platinum-resistant ...
The Food and Drug Administration has removed webpages about diversity and inclusion in clinical trials for cancer drugs. The page for Project Equity, a 2021 initiative launched by the FDA's Oncology ...